Atlas Wealth’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-780,335
Closed -$13M – 88
2024
Q2
$13M Buy
+780,335
New +$12.5M 1.52% 18
2023
Q4
– Sell
-542,642
Closed -$7.86M – 83
2023
Q3
$7.86M Sell
542,642
-5,995
-1% -$89.7K 1.47% 24
2023
Q2
$8.36M Sell
548,637
-1,888
-0.3% -$28.4K 1.54% 21
2023
Q1
$8.33M Sell
550,525
-20,787
-4% -$308K 1.64% 19
2022
Q4
$7.92M Buy
+571,312
New +$8.06M 2.14% 15

Other funds holding BCAT

Atlas Wealth's BCAT Position: Q3 2024 in Review

Atlas Wealth sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q3 2024, closing a stake of 780,335 shares — an estimated $13M sold.

Atlas Wealth first reported a position in BCAT in Q4 2022 and held it in 5 quarters. The position peaked at $13M in Q2 2024. 80 funds tracked by Wall St. Rank hold BCAT as of Q3 2024.

  • Atlas Wealth reported no remaining BlackRock Capital Allocation Term Trust position as of Q3 2024 after selling out during the quarter.
  • Atlas Wealth sold 780,335 BlackRock Capital Allocation Term Trust shares in Q3 2024, an estimated $13M.
  • Atlas Wealth first reported a position in BlackRock Capital Allocation Term Trust in Q4 2022 and held it in 5 quarters.
  • Atlas Wealth's BlackRock Capital Allocation Term Trust position peaked at $13M in Q2 2024.
  • 80 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q3 2024.

Based on Atlas Wealth's 13F filing for Q3 2024, filed 14 Nov 2024.